ARTICLE | Clinical News
DB289: Began Phase II trial
September 17, 2001 7:00 AM UTC
Immtech International Inc. (IMMT), Vernon Hills, Ill. Product: DB289 Business: Infectious diseases Therapeutic category: Cell proliferation Target: DNA minor groove Description: Binder of parasite DN...